A comprehensive view of Approved Drugs/Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca withdraws US COVID-19 vaccine application for Vaxzevria, shifts focus to antibody treatment Evusheld; Evusheld is approved in US to prevent COVID in immunocompromised people and in Europe as a preexposure prophylactic and as a treatment
Published: December 01, 2022 by Indian Pharma Industry: Policies
Baxter introduces ExactaMix Pro next-generation automated nutrition compounder at ASHP Meeting; device combines enhanced security with more intuitive and efficient features and greater processing power as compared to Baxter’s ExactaMix product
Published: December 01, 2022 by Business Wire
India approves AstraZeneca’s Dapagliflozin for diabetes patients with chronic kidney disease; the drug significantly reduces risk of sustained estimated glomerular filtration rate, cardiovascular deaths, hospitalizations due to heart failure
Published: December 01, 2022 by Financial Services Monitor Worldwide
AstraZeneca showcases strength of hematology portfolio and pipeline across multiple hard-to-treat conditions at ASH 2022 December 10-13; eight approved and potential new medicines to be featured across more than 10 types of blood cancers and rare diseases
Published: November 30, 2022 by Business Wire
World Health Organization updates emergency use listing for Novavax Nuvaxovid COVID-19 vaccine as a primary series in adolescents and as a booster in adults
Published: November 30, 2022 by PR Newswire

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count